NEW YORK (GenomeWeb) – Government and private payors should make greater use of databases and registries to determine if genomic testing helps personalize treatment for cancer patients and improves their outcomes, according to a commentary published today in Science by former National Cancer Institute Director Harold Varmus and the University of Michigan Law School's Rebecca Eisenberg.